Featured Story

Putney continues winning streak with launch of generic chewable Rimadyl

Putney was founded in Portland, ME, in 2006 with the goal of developing a pipeline of 20 generic drugs for the veterinary market, and it's well on the way to moving those products to market.

Aratana Therapeutics starts new canine study; reports good results on another

Pet meds developer Aratana Therapeutics has begun a pivotal field study of a new drug to treat postsurgery pain in dogs and reported positive results from another study for a product it hopes to use for the treatment of osteoarthritis in canines.

Bayer casts off equine drugs with 'no strategic relevance' to Sanofi's Merial

Bayer HealthCare announced Wednesday that it is handing its equine products Legend/Hyonate (hyaluronate sodium) and Marquis (ponazuril) to Sanofi's animal health company, Merial.

European and U.S. scientists warn veterinary meds are endangering wildlife

The veterinary nonsteroidal anti-inflammatory drug diclofenac was banned in several South Asian countries after the product was linked to mass deaths of vultures there. But diclofenac was recently approved in Spain and Italy--sparking an outcry from an international team of veterinarians, conservationists, and biologists, who argue that the drug will put Europe's vultures at risk of extinction.

Kansas State researchers model U.S. outbreak of foot-and-mouth

Veterinary researchers at Kansas State University have put together what they call the largest model of its kind that evaluates the effect and control of a potential outbreak of foot-and-mouth disease in livestock located in the central U.S.


From Our Sister Sites


Bristol-Myers Squibb has won a pioneering FDA approval for Opdivo (nivolumab), its top therapeutic asset in the pipeline, as a new therapy for melanoma.


Pharma companies are turning to experienced professionals to field questions from consumers at call centers, according to a new survey from Cutting Edge Information.